Malika Terahi
Algiers, Algeria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Increased Salivary Cytokines and Nitric Oxide Levels in Behçet's Disease: Interleukin-32, a Novel Player in Disease Prognosis.
Journal: Endocrine, metabolic & immune disorders drug targets
Published: December 01, 2021
In-vitro immunomodulatory effects of nicotine on Nitric Oxide, interleukin 1β and interleukin 37 production in human peripheral blood mononuclear cells (PBMC) from patients with Behçet disease.
Journal: International immunopharmacology
Published: May 26, 2021
Uric acid increases IL-1β secretion and Caspase-1 activation in PBMCs of Behçet's disease patients: The in vitro immunomodulatory effect of xanthine oxidase inhibitor Allopurinol.
Journal: International immunopharmacology
Published: November 15, 2019
Management Of Glaucoma In Developing Countries: Challenges And Opportunities For Improvement.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: June 17, 2019
Increased IL-1β levels are associated with an imbalance of "oxidant/antioxidant" status during Behçet's disease.
Journal: European cytokine network
Published: December 15, 2018
Influence of steroid hormones on the production of two inflammatory markers, IL-12 and nitric oxide, in Behçet's disease
Journal: Journal francais d'ophtalmologie
Published: August 02, 2015
In vivo and in vitro IL-18 production during uveitis associated with Behçet disease: effect of glucocorticoid therapy.
Journal: Journal francais d'ophtalmologie
Published: May 27, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026